19.87

0.08% 0.00

Bausch Lomb Corp (BLCO)

Overview News Price History Option Chain Financials Discussions Forecast

Bausch Lomb Corp stock is traded at $19.87, with a volume of 492.73K. It is up +0.08% in the last 24 hours and up +4.66% over the past month. Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Previous Close:

$19.87

Open:

$19.74

24h Volume:

492.73K

Relative Volume:

0.74

Market Cap:

$7.03B

Revenue:

$4.50B

Net Income/Loss:

$-456.00M

P/E Ratio:

-33.51

EPS:

-0.5929

Net Cash Flow:

$-137.00M

1W Performance:

-4.21%

1M Performance:

+4.66%

6M Performance:

+46.22%

1Y Performance:

+16.02%

1-Day Range:

$18.75

$20.00

1-Week Range:

$18.75

$20.94

52-Week Range:

$13.16

$21.69

Bausch Lomb Corp Stock (BLCO) Company Profile

Name

Bausch Lomb Corp

Sector

Healthcare (1181)

Industry

Medical Instruments & Supplies (58)

Phone

908-541-5456

Address

520 APPLEWOOD CRESCENT, VAUGHAN

Employee

13,300

Twitter

Next Earnings Date

2024-10-30

Latest SEC Filings

BLCO's Discussions on Twitter

Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-15-24	Upgrade	Evercore ISI	In-line → Outperform
Jul-10-24	Initiated	Raymond James	Outperform
May-06-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line
Dec-12-23	Initiated	Stifel	Hold
Oct-03-23	Resumed	Evercore ISI	Outperform
May-30-23	Resumed	Morgan Stanley	Equal-Weight
Mar-09-23	Initiated	Needham	Hold
Dec-21-22	Initiated	Barclays	Equal Weight
Sep-12-22	Initiated	H.C. Wainwright	Buy
Jul-26-22	Initiated	RBC Capital Mkts	Outperform
Jun-24-22	Initiated	Evercore ISI	Outperform
Jun-06-22	Initiated	Citigroup	Buy
May-31-22	Initiated	Deutsche Bank	Hold
May-31-22	Initiated	Goldman	Neutral
May-31-22	Initiated	Guggenheim	Buy
May-31-22	Initiated	JP Morgan	Neutral
May-31-22	Initiated	Jefferies	Buy
May-31-22	Initiated	Morgan Stanley	Equal-Weight
May-31-22	Initiated	Wells Fargo	Overweight
May-11-22	Initiated	Cowen	Outperform

View All

Bausch Lomb Corp Stock (BLCO) Latest News

Nov 02, 2024

Bausch & Lomb Secures $400 Million in New Term Loans - Investing.com India

Nov 02, 2024

Nov 01, 2024

Bausch & Lomb Secures $400 Million in New Term Loans By Investing.com - Investing.com South Africa

Nov 01, 2024

Bausch + Lomb Corporation (NYSE:BLCO) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 01, 2024

Oct 30, 2024

Bausch + Lomb Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 30, 2024

Bausch + Lomb Corporation Revises Earnings Guidance for the Full Year of 2024 - Marketscreener.com

Oct 30, 2024

Oct 29, 2024

Bausch & Lomb Corp (TSX:BLCO) Q3 2024 Earnings Report Preview: W - GuruFocus.com

Oct 29, 2024

Oct 27, 2024